Literature DB >> 15069144

Prospective matched-pair analysis of hydroxyapatite-coated and uncoated femoral stems in total hip arthroplasty. A concise follow-up of a previous report.

Javad Parvizi1, Peter F Sharkey, William J Hozack, Fabio Orzoco, Gina A Bissett, Richard H Rothman.   

Abstract

This prospective study was performed to examine the results of total hip arthroplasty with a tapered uncemented femoral component with and without hydroxyapatite coating in a matched-pair group of patients. Since our original publication in 1996, no femoral component was revised in either group. After a mean clinical and radiographic follow-up of 9.8 years, all femoral components were stable, with no evidence of progressive radiolucency or osteolysis. Ten acetabular components were revised because of aseptic loosening and wear. Our study demonstrated no clinical or radiographic advantage, during the first decade after implantation, to the use of hydroxyapatite on this design of femoral component in primary total hip arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15069144     DOI: 10.2106/00004623-200404000-00017

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  12 in total

1.  Excellent results with cementless total hip arthroplasty and alumina-on-alumina pairing: minimum ten-year follow-up.

Authors:  Alexander M Kress; Rainer Schmidt; Ulrich Holzwarth; Raimund Forst; Lutz A Mueller
Journal:  Int Orthop       Date:  2010-11-16       Impact factor: 3.075

2.  Enhanced cell integration to titanium alloy by surface treatment with microarc oxidation: a pilot study.

Authors:  Young Wook Lim; Soon Yong Kwon; Doo Hoon Sun; Hyoun Ee Kim; Yong Sik Kim
Journal:  Clin Orthop Relat Res       Date:  2009-05-12       Impact factor: 4.176

3.  Survival of the cementless Spotorno stem in the second decade.

Authors:  Peter R Aldinger; Alexander W Jung; Steffen J Breusch; Volker Ewerbeck; Dominik Parsch
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

4.  What Is the Risk of Revision Surgery in Hydroxyapatite-coated Femoral Hip Stems? Findings From a Large National Registry.

Authors:  Maria C Inacio; Michelle Lorimer; David C Davidson; Richard N De Steiger; Peter L Lewis; Stephen E Graves
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

5.  What works best, a cemented or cementless primary total hip arthroplasty?: minimum 17-year followup of a randomized controlled trial.

Authors:  Kristoff Corten; Robert B Bourne; Kory D Charron; Keegan Au; Cecil H Rorabeck
Journal:  Clin Orthop Relat Res       Date:  2010-07-13       Impact factor: 4.176

6.  A short-term follow-up study of a surgeon-customised fully-coated hydroxyapatite femoral stem using a nation-wide joint registry.

Authors:  Aneesh Dave; Bob Jang; Warwick Bruce
Journal:  J Orthop       Date:  2016-02-28

7.  Uncemented custom femoral components in hip arthroplasty. A prospective clinical study of 191 hips followed for at least 7 years.

Authors:  Pål Benum; Arild Aamodt
Journal:  Acta Orthop       Date:  2010-08       Impact factor: 3.717

Review 8.  Outcome of the cementless Taperloc stem: a comprehensive literature review including arthroplasty register data.

Authors:  Gerold Labek; Stefan Frischhut; Rainer Schlichtherle; Alexandra Williams; Martin Thaler
Journal:  Acta Orthop       Date:  2011-04       Impact factor: 3.717

Review 9.  Early subsidence of shape-closed hip arthroplasty stems is associated with late revision. A systematic review and meta-analysis of 24 RSA studies and 56 survival studies.

Authors:  Paul van der Voort; Bart G Pijls; Marc J Nieuwenhuijse; Jorrit Jasper; Marta Fiocco; Josepha W M Plevier; Saskia Middeldorp; Edward R Valstar; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2015       Impact factor: 3.717

10.  Reverse hybrid and cemented hip replacement compared using radiostereometry and dual-energy X-ray absorptiometry: 43 hips followed for 2 years in a prospective trial.

Authors:  Einar Lindalen; Jon Dahl; Lars Nordsletten; Finnur Snorrason; Øystein Høvik; Stephan Röhrl
Journal:  Acta Orthop       Date:  2012-11-01       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.